39 web-programmer-developer "PhD Jobs.NET" PhD positions at Nature Careers in Germany
Sort by
Refine Your Search
-
, regionally anchored top university as it focuses on the grand challenges of the 21st century. It develops innovative solutions for the world's most pressing issues. In research and academic programs
-
) investigates the pathobiology of human-pathogenic fungi and identifies targets for the development of novel natural product-based antibiotics. The research group Microbiome Dynamics (https://www.leibniz-hki.de
-
“planar scanning probe microscopy”, a flexible approach to scanning probe microscopy developed in our group (Ernst … Reinhard, ACS Photonics 6, 2 (2019)) to turn nanogap cavities into a scanning probe
-
. Dr. med. Alexander Busch investigates the regulation of the hypothalamic-pituitary-gonadal (HPG) axis—a key system in human reproductive development and fertility. The group combines clinical cohorts
-
The Leibniz-Institut für Analytische Wissenschaften - ISAS - e. V. develops efficient analytical methods for health research. Thus, it contributes to the improvement of the prevention, early
-
-pathogenic fungi and identifies targets for the development of novel natural product-based antibiotics. The research group Microbiome Dynamics (https://www.leibniz-hki.de/de/microbiome-dynamics.html ) invites
-
! RESPONSIBILITIES: You will elucidate the molecular mechanisms driving the development of distinct malignant lymphoma subtypes and contribute to the identification of predictive biomarkers and novel therapeutic
-
effector functions. Such understanding is essential for the development of new therapies against cancer and infectious diseases. Further information on our work can be found on our homepage and in our
-
young, dynamic, and interdisciplinary research team Access to state-of-the-art imaging technologies and preclinical research facilities A wide range of training, mentoring, and career development
-
, ideally with knowledge of Drosophila genetics and live imaging the applicant should be able to relocate for 6 months to our collaborator in Chile, where they will develop and optimize novel metabolite